Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

ACADIA PHARMACEUTICALS INC

Parent1 subsidiaryUEI: D79ND8GZR3E6CAGE: 5LB84

ACADIA PHARMACEUTICALS INC is a federal contractor, registered under UEI D79ND8GZR3E6 and CAGE code 5LB84. It has been awarded $600,000 across 8 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Phone+1 (555) 000-0000

Address123 Main St, City, ST 12345

Registration

UEI Code

D79ND8GZR3E6

CAGE Code

5LB84

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

272X

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Acadia Pharmaceuticals Inc. specializes in the manufacturing of pharmaceutical preparations, with a focus on developing and supplying specialized drugs, including those used in hematology and related therapeutic areas. The company leverages advanced pharmaceutical formulation technologies to produce...

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$600.0K100%

Awards by NAICS

- Unknown NAICS$600.0K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in ACADIA PHARMACEUTICALS INC's top NAICS codes and agencies

OHS Region 11 Training and Technical Assistance Network

Solicitation # 7571MN26C00013

The Department of the Interior’s existing contract with ICF Incorporated, LLC, numbered 140D0425C0027, has been administratively transferred to the Department of Health and Human Services under a new task order, 7571MN26C00013, effective July 1, 2026. This transfer is purely administrative and does not alter the original contract’s scope of work, deliverables, ultimate value, or period of performance. The work continues under the same terms and conditions, now managed by HHS to support the OHS Region 11 Training and Technical Assistance Network, with performance based in Reston, Virginia, and administrative oversight from Washington, DC. The contract, classified under NAICS code 541611, remains unrestricted with no set-aside requirements and is fully maintained under the original contractor’s responsibility. Point of contact for inquiries includes Carla Carter and Hamed Hassanzadeh Makou at HHS.

Department Of Health And Human Services

POSTED

about 2 months ago

DEADLINE

Portfolio Management System (OPS)

Solicitation # 7571MN26F80053

The Department of the Interior’s contract GS35F523BA/140D0422F0466, originally awarded to the Community Development Institute on May 11, 2022, for the Portfolio Management System (OPS), has been administratively transferred to the Department of Health and Human Services under the new contract number GS35F523BA/7571MN26F80053, effective June 12, 2026. This transfer does not modify any existing terms, including the ultimate contract value or the period of performance, and all scope of work, deliverables, and contractual obligations remain unchanged. The contract, identified by NAICS code 541511, is managed by HHS with the primary point of contact being Amber Harris at amber.harris@hhs.gov, and the work is performed in Madison, Wisconsin, while the contracting office is located in Washington, D.C. The contract notice was posted on June 15, 2026, and the change is purely administrative, with no impact on the contractor or the execution of the project.

Department Of Health And Human Services

POSTED

DEADLINE

NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

Solicitation # PA-27-102

This solicitation supports Small Business Technology Transfer (STTR) grants through the National Institutes of Health to fund research and development projects that advance innovative technologies with potential for commercialization, requiring a formal collaboration between a U.S.-owned small business and a nonprofit research institution. The award is made solely to the small business, regardless of where the principal investigator is employed, and projects must align with the missions of NIH, CDC, or FDA components. Funding is available for Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with Fast-Track allowing combined Phase I and II review to streamline the process. Direct to Phase II is an option for businesses that have already demonstrated technical merit without prior Phase I funding, provided the application is submitted as a new proposal, not a renewal. Only one Phase II award is permitted per Phase I project, and Phase IIB Strategic Breakthrough applications must go through a separate solicitation. Applications must focus on feasibility or R&D that supports public health goals and are subject to restrictions on clinical trials, which are not permitted under this NOFO if exclusively aligned with specific NIH institutes including NIAID, NIAMS, NIDCR, NIDDK, NIMHD, NCATS, and ORIP. The funding opportunity is part of the broader SBIR/STTR mandate, which requires NIH to set aside 0.45% of its extramural budget for STTR, ensuring support for small businesses with fewer than 500 employees. Applicants are encouraged to consult with program staff prior to submission to ensure alignment with funding priorities and to use the Assignment Request Form to suggest an appropriate awarding component, though such identification is not mandatory. The solicitation closes on August 5, 2026, and information on program details, priorities, and frequently asked questions is available through the NIH Seed Fund portal and related government strategies including the Make Our Children Healthy Again initiative.

Department of Health and Human Services

POSTED

DEADLINE

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Solicitation # PA-27-100

This funding opportunity supports U.S. small businesses in advancing early-stage research and development toward commercialization through the SBIR program, administered by the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration. Eligible small businesses must be U.S.-owned and operated with fewer than 500 employees and are expected to lead the majority of the technical effort, with the principal investigator primarily employed by the business. The program offers Phase I grants to establish technical feasibility, Phase II grants to advance development toward market readiness, and two special pathways: Direct to Phase II for projects with prior proof of concept but no prior Phase I award, and Fast-Track for combined Phase I and Phase II submissions reviewed concurrently to accelerate progress. All awards are granted to the small business, and commercialization must be pursued using non-SBIR funds after Phase II. The scientific scope must align with the missions of participating NIH, CDC, or FDA components, focusing on health improvement and public health innovation, with applicants encouraged to consult specific institute priorities and the White House’s Make Our Children Healthy Again Strategy. While clinical trials are permitted, they are explicitly excluded if the application aligns solely with certain NIH institutes or all FDA centers, making alignment critical for responsiveness. Applications must be submitted through the designated portal by the deadline, and while applicants are not required to specify an awarding component during submission, consultation with program staff beforehand is strongly advised to ensure proper alignment. The solicitation operates under a complete small business set-aside mandate and is open to new applications only, with no renewals accepted for Direct to Phase II submissions.

Department of Health and Human Services

POSTED

DEADLINE

SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

Solicitation # PAR-27-098

The Commercialization Readiness Pilot (CRP) program, issued under PAR-27-098, provides late-stage research and development funding and technical assistance to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award or a Phase IIB Strategic Breakthrough award. This initiative is designed to bridge the gap between Phase II completion and full commercialization by supporting activities that require significant outsourcing, such as regulatory strategy, intellectual property development, manufacturing optimization, pre-clinical product development, and clinical trials—though not all NIH institutes accept clinical trial proposals. The program permits substantial outsourcing to contract research organizations but requires the small business to maintain active oversight and management of all scientific, financial, and administrative aspects of the work, with justified budget allocations reflecting this role. CRP funding cannot cover FDA filing fees or include separate Technical and Business Assistance (TABA) funds. Eligible applicants must be small business concerns under 500 employees meeting SBA size standards, and proposals must align with the mission of participating NIH components. The solicitation explicitly excludes applications that propose clinical trials solely aligned with certain NIH institutes, including NHLBI, NIAID, NIDDK, and others listed, which do not accept such trials under this program. Applications are limited to Type 1 new submissions, and prior Phase II funding is mandatory for eligibility. Applicants are strongly encouraged to consult with NIH program staff before submitting to ensure alignment with the most appropriate funding mechanism, as the Phase IIB Strategic Breakthrough program (PA-27-101) may be better suited for some projects with matching fund requirements. The solicitation is active through August 5, 2026, under a total small business set-aside, and further details are available through the NIH SBIR/STTR portal.

Department of Health and Human Services

POSTED

DEADLINE

in over 2 years

Office of Head Start Monitoring Support - Aligned Monitoring System 2.0 – Digital Strategy

Solicitation # GS35F284CA-7571MN26F80017

The contract originally awarded to Arch Systems, LLC by the Department of the Interior on March 26, 2026, under contract number 140D0425F0866, has been administratively transferred to the Department of Health and Human Services (HHS) effective March 29, 2026. The new task order number for this contract under HHS is GS35F284CA/7571MN26F80017. This transition does not affect any of the original contract’s terms, including the ultimate contract value and period of performance, nor does it change the work scope, deliverables, or any contractual obligations. The contract supports the Office of Head Start Monitoring through the Aligned Monitoring System 2.0, focusing on digital strategy enhancements. It is a total small business set-aside under NAICS code 541511 and is being administered by the Department of Health and Human Services based in Washington, DC, with performance taking place in Baltimore, Maryland. Primary points of contact for this contract at HHS are Carla Carter and Hamed Hassanzadeh Makou, who can be reached via email for any inquiries related to the contract.

Department Of Health And Human Services

POSTED

DEADLINE

Vehicle Recompete: Bpa 75FCMC22A0027This contract is a blanket purchase agreement (BPA) with a ceiling value of $1 billion, established by the Department of Health and Human Services through the Office of Acquisition and Grants Management. It covers examinations of Medicare Advantage Organizations (MAOs) and Prescription Drug Plans (PDPs), specifically focusing on financial audits and related assessments. The agreement is set to remain active until September 22, 2027, and is a full recompete, indicating a renewal or continuation of previous contractual arrangements. Although there are currently no active task orders under this BPA, a notable subcontractor, Myers & Stauffer LC, has previously been awarded a task order valued at approximately $2.3 million for financial audits of Medicare Advantage Organizations and Prescription Drug Plans. The contract aligns with NAICS code 541211, which pertains to audits and accounting services. This arrangement supports ongoing oversight and compliance activities critical to the integrity and financial accuracy of Medicare-related plans.

Ofc Of Acquisition And Grants Management

POSTED

DEADLINE

Vehicle Recompete: Bpa 75FCMC22A0023This contract is a blanket purchase agreement (BPA) with the Department of Health and Human Services, managed by the Office of Acquisition and Grants Management, focused on conducting examinations of Medicare Advantage Organizations (MAOs) and Prescription Drug Plans (PDPs). The BPA has a ceiling value of $50 million and is active until September 22, 2027. Currently, there are no active task orders under this BPA, though previously there was a notable task order valued at over $2.2 million awarded to Bland & Associates PC for one-third financial audits related to MAOs and PDPs. The contract is classified as a full-recompete vehicle, indicating it is part of a competitive renewal process to continue these examination services. It falls under the NAICS code 541211, which pertains to offices of certified public accountants and related services, aligning with the contract’s focus on financial and compliance audits. This contract enables the Department of Health and Human Services to procure audit and examination services efficiently over an extended period, ensuring oversight and compliance for Medicare Advantage and Prescription Drug Plan operations.

Ofc Of Acquisition And Grants Management

POSTED

DEADLINE

Vehicle Recompete: Bpa 75FCMC22A0024This contract is a blanket purchase agreement (BPA) designated as vehicle 75FCMC22A0024, which is intended for the examination of Medicare Advantage Organizations (MAOs) and Prescription Drug Plans (PDPs). The ordering period for this BPA extends through September 22, 2027. It is managed by the Office of Acquisition and Grants Management under the Department of Health and Human Services. Currently, there are no active task orders under this agreement, with a total value of zero at this time. One significant task order under this BPA, valued at approximately $2.3 million, has been awarded to Davis Farr LLP for conducting examinations related to Medicare Advantage and Prescription Drug Plans. The contract is classified as a full recompete, indicating a process for selecting the vendor through competitive means. The associated NAICS code for the contract is 541211, which relates to offices of certified public accountants and auditing services. This BPA provides a structured vehicle for executing audits and examinations essential to ensuring the integrity and compliance of Medicare Advantage and Prescription Drug Plan providers.

Ofc Of Acquisition And Grants Management

POSTED

DEADLINE

Vehicle Recompete: Idc 75H71225D00001This contract, identified as Idc vehicle 75H71225D00001, is set to remain active until September 21, 2027, with no current active task orders valued at zero. The overall contract ceiling is $1,385,100, managed by the Phoenix Area Indian Health Service office under the Department of Health and Human Services. It is classified as a recompete-likely contract with medium confidence, indicating an expectation for renewal or continuation. The contract focuses on providing maintenance and repair services for medical-grade refrigerators and freezers, critical equipment for healthcare operations. A notable task order within this contract is for preventive maintenance and repair services for medical grade refrigerators and freezers, spanning a base year from November 1, 2024, through October 31, 2025, with a ceiling amount of $270,000. One of the top task orders awarded is valued at $87,350 and is designated for the Phoenix Area Indian Health Service on an area-wide basis, contracted to Helmer Scientific LLC. The contract is not designated as a set-aside, and the primary NAICS code associated with it is 811310, reflecting relevant maintenance and repair services.

Phoenix Area Indian Health Svc

POSTED

DEADLINE

Vehicle Recompete: Idc 75N95022D00020This contract, identified as IDC vehicle 75N95022D00020, supports Blueprint Medtech (BPMT) regulatory affairs and related services, with an ordering period extending from September 22, 2022, to September 21, 2027. It is managed by the National Institutes of Health, specifically the National Institute on Drug Abuse, under the Department of Health and Human Services. The contract has a ceiling value of $24 million and was awarded without any set-aside considerations. It is classified as a full-recompete contract, indicating a high confidence level in its competitive procurement process. Currently, there are no active task orders under this contract valued at zero, though notable task orders include regulatory consulting assistance for medical device development, research and development for clinical studies within the Blueprint Medtech initiative, and pre-submission assessment and package preparation. One significant task order, running from April 9, 2024, to April 8, 2029, was awarded to PPD Development LP for $370,621. The contract operates under NAICS code 541715 and primarily focuses on supporting clinical and regulatory activities related to medical device development.

National Institutes Of Health Nida

POSTED

DEADLINE

Vehicle Recompete: Idc 75D30122D13482This contract, identified as Idc vehicle 75D30122D13482, is an Architect-Engineer (A-E) Indefinite Delivery Indefinite Quantity (IDIQ) agreement for facilities planning and real estate advisory services. It has a ceiling value of $12,052,560 and is managed by the CDC Office of Acquisition Services under the Department of Health and Human Services. The ordering period for this contract extends through September 14, 2027, and there are currently no active task orders. The contract was established as a full-recompete with a high confidence rating, indicating a strong likelihood of continued use or recompete opportunities. One of the top task orders under this contract is valued at over $4.1 million and has been awarded to Jacobs Government Services Company for A-E IDIQ services related to facilities planning and real estate advisory. The contract falls under NAICS code 541330, which covers engineering services, and does not utilize any set-asides. The contract's administrative and performance details show it is focused on supporting the Department of Health and Human Services, specifically through the CDC acquisition office, although specific location or point of contact information is not provided.

CDC Office Of Acquisition Services

POSTED

DEADLINE

Vehicle Recompete: Idc 75F40122D00014This contract, identified as Idc vehicle 75F40122D00014, is a small business set-aside managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. It has a ceiling value of $65,010,000 with an ordering period extending through September 14, 2027. The contract supports the FDA’s Center for Tobacco Products (CTP), specifically the Office of Compliance and Enforcement (OCE), which regulates tobacco products, manufacturers, and retailers to ensure compliance with federal laws. Although currently there are no active task orders under this vehicle, it has supported significant work previously, including a major task order for the processing of retailer compliance check inspection data valued at over $6.6 million awarded to MPF-ZAI Solutions LLC. The contract involves services that broadly cover compliance and enforcement functions related to tobacco control, with an emphasis on data management and regulatory oversight. It is classified as a full recompete vehicle under NAICS code 541611 and is designed exclusively for small business participation.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Vehicle Recompete: Bpa 75H71123A00121The contract BPA vehicle 75H71123A00121, managed by the Indian Health Service under the Department of Health and Human Services, is focused on diabetic foot supplies and services. It has an indefinite delivery vehicle (IDV) ceiling of $245,000 with no active task orders currently underway, though it includes a past task order valued at $50,000 awarded to Mid Star Lab Inc. The ordering period for this contract extends until September 14, 2027. The contract is identified as a recompete with medium confidence, indicating that it is likely to be renewed or competed again in the future. This contract covers procurement under NAICS code 316210 and serves the Indian Health Service's requirements related to diabetic foot care products and services. While specific details on the solicitation and place of performance are not provided, the contract remains an important procurement vehicle supporting healthcare-related supply needs within the Department of Health and Human Services framework. The contract is currently in a pre-forecast stage, with the recompete process anticipated to begin around March 2026.

Indian Health Service

POSTED

DEADLINE

Vehicle Recompete: Bpa 75R60222A00041This contract, identified as BPA vehicle 75R60222A00041, focuses on providing medical expert services related to the Vaccine Injury Compensation Program (VICP) and the Countermeasures Injury Compensation Program (CICP) under the Department of Health and Human Services via the HRSA Headquarters. The ordering period for this contract ends on September 8, 2027, with an overall ceiling value set at $7.5 million. Currently, no active task orders are outstanding under this contract. It is classified as a recompete-likely contract with medium confidence regarding its future continuation. The contract includes several past task orders for medical expert services, predominantly awarded to Brian C. Callaghan, with individual task order values ranging from approximately $11,250 to $22,500. These task orders specifically pertain to medical expert reviews and case evaluations within the VICP, emphasizing the contract's role in supporting expert medical assessments related to vaccine injury claims. The solicitation and procurement activity is managed by HRSA Headquarters under NAICS code 541611, which covers administrative and management consulting services, although specific geographical details related to performance and contact points are not listed.

Hrsa Headquarters

POSTED

DEADLINE

Vehicle Recompete: Bpa 75R60222A00040This contract pertains to medical expert services supporting the Vaccine Injury Compensation Program (VICP) under the Department of Health and Human Services, managed by the HRSA Headquarters. The ordering period for the BPA vehicle 75R60222A00040 extends until September 7, 2027, with an overall ceiling value of $7.5 million. Although there are currently no active task orders valued at zero, previous task orders within this vehicle indicate engagement with experts such as Whitton J Lindsay, with task order values of $24,375 and $15,000 respectively. The contract is classified as a likely recompete opportunity with a medium confidence level. It involves services under the NAICS code 541611, which typically covers administrative management and general management consulting services. The contract appears to be in a pre-forecast stage, posted in March 2026, with no specific solicitation number or detailed location information provided. Overall, this contract vehicle facilitates access to specialized medical expertise essential for adjudicating vaccine injury claims within a federal healthcare program.

Hrsa Headquarters

POSTED

DEADLINE

Vehicle Recompete: Idc 75N95022D00017This contract is an indefinite delivery contract vehicle (IDC) with the identifier 75N95022D00017, overseeing the ordering period from September 5, 2022, through September 4, 2027. It supports the National Institute on Drug Abuse (NIDA) data, statistics, and clinical trial operations under the Department of Health and Human Services, managed by the National Institutes of Health (NIH). The contract has a ceiling value of approximately $44.3 million and does not involve any set-aside provisions. It represents a full recompete classification, indicating a competitive solicitation process to award the contract. Currently, there are no active task orders valued at zero, but several significant task orders have been executed under this vehicle. Several key task orders highlight the contract’s scope and value, all awarded to The Emmes Company, LLC. These task orders cover a variety of research and analytical services, including the management and support of the Data and Statistics Center (DSC) from March 2025 to February 2026 ($1.85 million), data analysis related to GLP-1 as an adjunct to buprenorphine from May 2025 to February 2028 ($1.4 million), and various other clinical and secondary analysis projects concerning opioid use disorder and related research, with task order values ranging from approximately $375,000 to $800,000. The work performed under these task orders reflects a comprehensive support framework for clinical trials and data management activities essential to advancing research efforts around drug abuse and treatment strategies.

National Institutes Of Health Nida

POSTED

DEADLINE

Vehicle Recompete: Idc 75N99019D00014This contract, identified as Idc vehicle 75N99019D00014, is a multiple award construction agreement managed by the NIH A E Construction office under the Department of Health and Human Services. The ordering period for this contract concludes on September 4, 2027, with a substantial IDV ceiling of $2.5 billion. It is a full recompete contract that is not set aside for any specific small business category. Currently, there are no active task orders valued at zero under this vehicle. Among the notable task orders previously awarded is a significant construction project for the Clinical Center Radiopharmacy/Biologics Radiolabeling Facility, with a contract value of nearly $24.8 million awarded to The Whiting-Turner Contracting Company. The contract falls under the NAICS code 236220, which pertains to commercial and institutional building construction. The contract's upcoming recompete forecast was posted in March 2026, signaling continued opportunities in health-related construction services managed by NIH A E Construction.

NIH A E Construction

POSTED

DEADLINE